On November 5th, 2018 IMMUNONET is hosting a Public-Private Partnership in Immuno-Oncology workshop. The workshop includes presentations by thirteen researchers and research leaders from Danish universities, hospitals, and private biotech and pharmaceutical companies and begins with a keynote presentation by Martin Bonde, CEO at the Norwegian biopharmaceutical company Vaccibody AS. The thirteen presenters will present the immuno-oncology research at their department or company, and their experiences from previous collaborations between academia and industry. The focus will be on present challenges in public-private partnerships and on opportunities for new collaborations. The conference will take place at COBIS A/S in Copenhagen. The programme begins with registration at 13:15 and ends at 18:15 with a light dinner. The full programme is available at the IMMUNONET homepage https://immunonet.dk/. Participation in the workshop is free of charge. Registration is open at https://immunonet.dk/.